Starting
Initialising…
0%
SF3B1
Final classification
VUS
SF3B1 c.1873C>T · p.Arg625Cys
SF3B1

The SF3B1 c.1873C>T (p.Arg625Cys; p.R625C) variant has been observed repeatedly in somatic cancers and is recorded in ClinVar, while published studies identify codon 625 as a recurrently mutated SF3B1 hotspot.

Gene
SF3B1
Transcript
NM_012433.2
HGVS · transcript:coding
NM_012433.2:c.1873C>T
Consequence
N/A
GRCh38
chr2:197402760 G>A
GRCh37
chr2:198267484 G>A
Basis gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM1 moderate, PM2 supporting, PP3 supporting; combination = 1 moderate + 2 supporting, which maps to VUS.
gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM1 moderate, PM2 supporting, PP3 supporting; combination = 1 moderate + 2 supporting, which maps to VUS.
Classification rationale
PM1PM2PP3 VUS
SF3B1 c.1873C>T

The SF3B1 c.1873C>T (p.Arg625Cys; p.R625C) variant has been observed repeatedly in somatic cancers and is recorded in ClinVar, while published studies identify codon 625 as a recurrently mutated SF3B1 hotspot.1 This variant is rare in population databases, with 1/251128 alleles in gnomAD v2.1 (AF 3.98203e-06; 0.00040%) and 3/1613820 alleles in gnomAD v4.1 (AF 1.85894e-06; 0.00019%), both below the 0.1% PM2 threshold.2 In published functional studies, SF3B1 hotspot-mutant tumors and model systems showed altered alternative splicing and abnormal 3' splice-site selection, supporting functional importance of the codon 625 region, although exact p.Arg625Cys assay-level evidence remains limited.3 Computational evidence supports a deleterious missense effect, with REVEL 0.823 and BayesDel 0.321224, while SpliceAI predicts no significant splice disruption with a maximum delta score of 0.03.4

PM1 + PM2 + PP3 VUS
Gene diagram · NM_012433.2 · variants mapped to exon structure
SF3B1 NM_012433.2
Fetching transcript structure from UCSC…
Applied criteria · 3 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      This variant is present in gnomAD v4.1 (AF= 1.85894e-06; MAF= 0.00019%, 3/1613820 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 2.54257e-06; MAF= 0.00025%, 3/1179908 alleles, homozygotes = 0); grpmax FAF= 6.8e-07.
      v2.1
      This variant is present in gnomAD v2.1 (AF= 3.98203e-06; MAF= 0.00040%, 1/251128 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 8.81228e-06; MAF= 0.00088%, 1/113478 alleles, homozygotes = 0).
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      0.00019% · 3 / 1,613,820
      0 hom · FAF 6.8e-05%
      European (non-Finnish)
      3 / 1,179,908
      0.00025%
      + 9 not observed (Remaining individuals, Admixed American, European (Finnish), Amish, East Asian, Middle Eastern, South Asian, Ashkenazi Jewish, African/African American)
      gnomAD v2.1
      0.0004% · 1 / 251,128
      0 hom
      European (non-Finnish)
      1 / 113,478
      0.00088%
      + 7 not observed (African/African American, Admixed American, Ashkenazi Jewish, East Asian, European (Finnish), Remaining individuals, South Asian)
      ClinVar screenshot
      ClinVar
      This variant has been reported in ClinVar but submission details could not be extracted.
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.03). REVEL score = 0.823. BayesDel score = 0.321224.
      Functional / OncoKB screenshot
      Functional Likely Oncogenic
      OncoKB identified variant-specific curated literature and context relevant to functional review; curated oncogenicity label: Likely Oncogenic.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant lies in a statistically significant hotspot. This variant has previously been reported in somatic cancers (COSMIC; COSV59205859, n = 105 times).
      Hotspots
      This variant lies in a statistically significant hotspot.
      Literature · how each cited paper was used
      5papers cited
      Each card is an audit: what was searched, what was found, whether it names the variant, which criteria it fed, and why.
      PMID PMID:23313955
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PM1 supports · met
      PMID PMID:23861464
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PM1 supports · met
      PMID PMID:24434863
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PM1 supports · met
      PMID PMID:26565915
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PM1 supports · met
      PMID PMID:33031100
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PM1 supports · met
      Sources & reference links
      7Sources
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots